AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildalip-Met 50/850 Tablet

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Vildalip-Met 50/850 Tablet

Metformin-Vildagliptin 50/850mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). This medication may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized, factoring in your health status, blood glucose readings, and current medications. Consuming it with meals minimizes gastrointestinal distress. Consistent daily intake, at the same time, maximizes benefits; discontinuation should only occur under physician guidance. Effective blood sugar control reduces the risk of future complications. Continued commitment to your doctor's recommended diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, fatigue, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn its recognition and management. This medication isn't suitable for all individuals. Inform your doctor about pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating women should consult their physician. Interaction with other medications is possible; disclose all current medications for safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Vildalip-Met 50/850 Tablet

There is no text provided to rephrase.

Uses of Vildalip-Met 50/850 Tablet

Managing Type 2 diabetes

Major Benefits of Vildalip-Met 50/850 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildalip-Met 50/850 Tablets should be administered with a meal.

Common Side effects of Vildalip-Met 50/850 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildalip-Met 50/850 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for Vildalip-Met 50/850 Tablets. Ingest each tablet whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.

How Vildalip-Met 50/850 Tablet works:

Metformin/Vildagliptin 850mg/50mg tablets combine two diabetes medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vildalip-Met 50/850 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildalip-Met 50/850 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildalip-Met 50/850 tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildalip-Met 50/850 tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vildalip-Met 50/850 tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Vildalip-Met 50/850 Tablet :

Should you forget a Vildalip-Met 50/850 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildalip-Met 50/850 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Vildalip-Met 50/850 Tablet

Vildalip-Met 50/850 Tablets rarely cause hypoglycemia by themselves, but it can happen if calorie intake is inadequate. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are used concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildalip-Met 50/850 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildalip-Met 50/850 Tablets are contraindicated in patients with known allergies to its components or excipients. This medication is also harmful for individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Vildalip-Met 50/850 tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Vildalip-Met 50/850 Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vildalip-Met 50/850 Tablet and seek immediate medical attention.
Prolonged Vildalip-Met 50/850 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildalip-Met 50/850 Tablet is safe when taken as directed by your doctor. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially when combined with insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vildalip-Met 50/850 Table...
134
MRP 155
13% off